Tolerance to a dominant T cell epitope in the acetylcholine receptor molecule induces epitope spread and suppresses murine myasthenia gravis

Journal of Immunology

Volumn 159, Issue 6, 1997, Pages 3016-3023

  Wu, Bo ^a,b   Deng, Caishu ^a   Goluszko, Elzbieta ^a   Christadoss, Premkumar ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINERGIC RECEPTOR; EPITOPE; PEPTIDE FRAGMENT;

AMINO ACID SEQUENCE; ANIMAL; ARTICLE; CHEMISTRY; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; MOLECULAR GENETICS; MOUSE; MYASTHENIA GRAVIS; T LYMPHOCYTE;

AMINO ACID SEQUENCE; ANIMALS; IMMUNE TOLERANCE; IMMUNODOMINANT EPITOPES; MICE; MOLECULAR SEQUENCE DATA; MYASTHENIA GRAVIS; PEPTIDE FRAGMENTS; RECEPTORS, CHOLINERGIC; T-LYMPHOCYTES;

EID: 0031571784     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Bach, J. 1993. Immunosuppressive therapy of autoimmune diseases. Immunol. Today 14:322.
2. Critchfield, J. M., M. K. Racke, J. C. Zuniga-Pflucker, B. Cannella, C. S. Raine, J. Goverman, and M. Lenardo. 1994. T cell deletion in high antigen dose therapy of autoimmune encephalomyelitis. Science 263:1139.
3. Guar, A., B. Wiers, A. Liu, J. Rothbard, and C. G. Fathman. 1992. Amelioration of autoimmune encephalomyelitis by myelin basic protein synthetic peptide-induced anergy. Science 258:1491.
4. Hohlfeld, R., I. Kalies, B. Kohleisen, K. Heininger, B. Conti-Tranconi, and K. V. Toyka. 1986. Myasthenia gravis: stimulation of antireceptor autoantibodies by autoreactive T cell lines. Neurology 36:618.
5. Christadoss, P., and M. J. Dauphinee. 1986. Immunotherapy for myasthenia gravis: a murine model. J. Immunol. 136:2437.
6. Patrick, J., and J. M. Lindstrom. 1973. Autoimmune response to acetylcholine receptor. Science 180:871.
7. Christadoss, P., 1989. Immunogenetics of experimental autoimmune myasthenia gravis. Crit. Rev. Immunol. 9:247.
8. Drachman, D. B. 1994. Myasthenia gravis. N. Engl. J. Med. 330:1797.
9. Kaul, R., M. Shenoy, and P. Christadoss. 1994. The role of major histocompatibility complex genes in myasthenia gravis and experimental autoimmune myasthenia gravis pathogenesis. Adv. Neuroimmunol. 4:387.
10. Kaul, R., M. Shenoy, E. Goluszko, and P. Christadoss. 1994. MHC class II gene disruption prevents experimental autoimmune myasthenia gravis. J. Immunol. 152:3152.
11. Christadoss, P., J. Lindstrom, S. Muno, and N. Talal. 1985. I-A subregion mutation prevents murine experimental autoimmune myasthenia gravis. Immunogenetics 21:33.
12. Shenoy, M., M. Oshima, M. Z. Atassi, and P. Christadoss. 1993. Suppression of experimental autoimmune myasthenia gravis by epitope-specific neonatal tolerance to synthetic region α146-162 of acetylcholine receptor. Clin. Immunol. Immunopathol. 66:230.
13. Sheony, M., E. Goluszko, and P. Christadoss. 1994. The pathogenic role of acetylcholine receptor α chain epitope within α146-162 in the development of experimental autoimmune myasthenia gravis in C57BL6 mice. Clin. Immunol. Immunopathol. 73:338.
14. Wu, B., E. Goluszko, and P. Christadoss. Experimental autoimmune myasthenia gravis in mice. 1997. In Protocols in Immunology Vol. 3. J. E. Coligan, A. M. Kruisbeak, D. H. Margulies, E. M. Shevach, and W. Strober, eds. John Wiley & Sons, New York, p. 15.8.1.
15. Prabhakar, B. S., G. P. Allaway, J. Srinivasappa, and A. L. Notkins. 1990. Cell surface expression of the 70-KD component of Ku, a DNA-binding nuclear autoantigen. J. Clin. Invest. 86:1301.
16. Christadoss, P., J. M. Lindstrom, N. Talal, C. R. Duvic, A. Kalantri, and M. Shenoy. 1986. Immune response gene control of lymphocyte proliferation induced by acetylcholine receptor-specific helper factor derived from lymphocytes of myasthenic mice. J. Immunol. 137:1845.
17. Singh, R. R., F. M. Ebling, E. E. Sercarz, and B. Hahn. 1995. Immune tolerance to autoantibody peptides delays development of autoimmunity in murine lupus. J. Clin. Invest. 96:2990.
18. Tian, J., M. A. Atkinson, M. Clare-Salzler, A. Herschenfeld, T. Forsthuber, P. V. Lehmann, and D. L. Caufman. 1996. Nasal administration of glutamate decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes. J. Exp. Med. 183:1561.
19. + T cells. J. Exp. Med. 184:19.
20. Guery, J. C., F. Galbiati, S. Smiroldo, and L. Adorini. 1996. Selective development of T helper (Th2) cells induced by continuous administration of low dose soluble proteins to normal and β2-microglobulin-deficient BALB/c mice. J. Exp. Med. 183:485.
21. Forsthuber T., H. C. Yip, and P. V. Lehmann. 1996. Induction of TH1 and TH2 immunity in neonatal mice. Science 271:1728.
22. Singh, R. R., B. H. Hahn, and E. E. Sercarz. 1996. Neonatal peptide exposure can prime T cells and, upon subsequent immunization, induce their immune deviation: implications for antibody vs. T cell-mediated autoimmunity. J. Exp. Med. 183:1613.
23. Barrett, S. P., P. A. Gleeson, H. de Silva, B. H. Toh, and I. van Driel. 1995. Interferon-γ is required during the initiation of an organ-specific autoimmune disease. Eur. J. Immunol. 26:1652.
24. Ozmen, L., D. Roman, M. Fountoulakis, G. Schmid, B. Ryffel, and G. Garotta. 1995. Experimental therapy of systemic lupus erythematosus: the treatment of NZBAV mice with mouse soluble Interferon gamma receptor inhibits the onset of glomerulonepheritis. Eur. J. Immunol. 25:6.